In a recent study wharton s jelly tissue transplantation has shown to be able to reduce traumatic brain injury and may have therapeutic potential.
Whartons jelly derived mesenchymal stem cells.
Wharton s jelly derived mesenchymal stem cells wj mscs have been introduced as a possible therapy in hypoxic ischemic encephalopathy hie.
2 polish stem cell bank grzybowska 2 41 00 131 warsaw poland.
Wharton s jelly is therefore a potential source of adult stem cells often collected from cord blood.
A recent publication in biomed research international has reviewed the study on the potential benefits of wharton s jelly derived mesenchymal stem cells in treating a variety of diseases.
Thus more research is needed on the isolation and characterization of mesenchymal ste.
We report a 16 year old boy who was treated with wj mscs in the course of hie due to post cardiopulmonary resuscitation.
Wharton s jelly derived mesenchymal stem cells may have immunomodulatory effect on lymphocytes.
They are known as regenerative medicine.
Wharton s jelly derived mesenchymal stem cells wj mscs have a high proliferation valency and they do not produce teratogen or carcinogen after subsequent transplantation.
Evidences that these cells possess therapeutic properties are constantly accumulating.